Financial Anika Reports Fourth Quarter and Full Year 2017 Financial Results byJosh SandbergFebruary 21, 2018
Biologics Anika Completes Enrollment in Second Pivotal Phase III Trial of CINGAL for the Treatment of Knee Pain Associated with Osteoarthritis byJosh SandbergOctober 26, 2017
Financial Top Stories Anika Announces $5 Million Milestone Payment from U.S. Commercial Sales of MONOVISC byJosh SandbergJuly 18, 2017
Extremities Anika Announces Publication of Phase III Data Demonstrating the Efficacy and Safety of CINGAL® byJosh SandbergMay 23, 2017
Financial Anika Reports Fourth Quarter and Full Year 2016 Financial Results byJosh SandbergFebruary 16, 2017
Financial THE OLD MUTUAL GLOBAL INVESTORS UK LTD. INVESTS $901,000 IN ANIKA THERAPEUTICS INC. (ANIK) byJosh SandbergFebruary 6, 2017
Top Stories Anika Announces European Commercial Launch of CINGAL for the Treatment of Pain Associated with Osteoarthritis byJosh SandbergJune 2, 2016
Extremities Anika Therapeutics Announces Canadian Launch of CINGAL for the Treatment of Pain Associated with Osteoarthritis of the Knee byJosh SandbergMay 20, 2016
